Treating psychiatric symptoms and disorders with non-psychotropic medications


A few drugs prescribed in internal medicine, ie, non-psychotropic drugs, can be used to treat certain neuropsychiatric disorders. For most of these situations, the level of evidence remains low. But when sufficient data becomes available, these molecules are then included in official guidelines for...

Descripción completa

Detalles Bibliográficos
Autores principales: Hede, Vincent, Devillé, Cédric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Les Laboratoires Servier 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787535/
https://www.ncbi.nlm.nih.gov/pubmed/31636493
http://dx.doi.org/10.31887/DCNS.2019.21.2/vhede
_version_ 1783458285717815296
author Hede, Vincent
Devillé, Cédric
author_facet Hede, Vincent
Devillé, Cédric
author_sort Hede, Vincent
collection PubMed
description A few drugs prescribed in internal medicine, ie, non-psychotropic drugs, can be used to treat certain neuropsychiatric disorders. For most of these situations, the level of evidence remains low. But when sufficient data becomes available, these molecules are then included in official guidelines for the treatment of neuropsychiatric disorders. In this article we review interesting drugs which may be relevant from an evidence-based medicine point of view, and could become part of psychiatric practice in the future.

format Online
Article
Text
id pubmed-6787535
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Les Laboratoires Servier
record_format MEDLINE/PubMed
spelling pubmed-67875352019-10-21 Treating psychiatric symptoms and disorders with non-psychotropic medications
 Hede, Vincent Devillé, Cédric Dialogues Clin Neurosci Original Article A few drugs prescribed in internal medicine, ie, non-psychotropic drugs, can be used to treat certain neuropsychiatric disorders. For most of these situations, the level of evidence remains low. But when sufficient data becomes available, these molecules are then included in official guidelines for the treatment of neuropsychiatric disorders. In this article we review interesting drugs which may be relevant from an evidence-based medicine point of view, and could become part of psychiatric practice in the future.
 Les Laboratoires Servier 2019-06 /pmc/articles/PMC6787535/ /pubmed/31636493 http://dx.doi.org/10.31887/DCNS.2019.21.2/vhede Text en © 2019, AICH – Servier GroupCopyright © 2019 AICH – Servier Group. All rights reserved http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Hede, Vincent
Devillé, Cédric
Treating psychiatric symptoms and disorders with non-psychotropic medications

title Treating psychiatric symptoms and disorders with non-psychotropic medications

title_full Treating psychiatric symptoms and disorders with non-psychotropic medications

title_fullStr Treating psychiatric symptoms and disorders with non-psychotropic medications

title_full_unstemmed Treating psychiatric symptoms and disorders with non-psychotropic medications

title_short Treating psychiatric symptoms and disorders with non-psychotropic medications

title_sort treating psychiatric symptoms and disorders with non-psychotropic medications

topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787535/
https://www.ncbi.nlm.nih.gov/pubmed/31636493
http://dx.doi.org/10.31887/DCNS.2019.21.2/vhede
work_keys_str_mv AT hedevincent treatingpsychiatricsymptomsanddisorderswithnonpsychotropicmedications
AT devillecedric treatingpsychiatricsymptomsanddisorderswithnonpsychotropicmedications

Ejemplares similares